Lifevantage

LFVNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$85.283 M

$6.76 +2.74%

Close of 7 Aug 2026

Revenue

$228.5M

#2257 by revenue

Earnings

$9.80M

#2053 by earnings

Shares outstanding

12,615,822

Latest filing cover page

P/E ratio

8.7

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#316MAIA BiotechnologyMAIA$86.3M
#317RallybioRLYB$85.6M
#318LifevantageLFVN$85.3M
#319Alterity TherapeuticsATHE$80.7M
#320Telomir PharmaceuticalsTELO$79.8M

Where these numbers come from

Share counts and financials for Lifevantage are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.